Business
-
According to Savara Pharmaceuticals, the company has created a Clinical Advisory Board to provide advice on the development of AeroVanc vancomycin hydrochloride inhalation powder for the treatment of MRSA lung infections in patients with cystic… Read more . . .
-
The Bluetooth Special Interest Group (SIG) has named Asthmapolis the winner in the Product Category of the Bluetooth Breakthrough Awards. The awards recognize innovative products and apps that use Bluetooth wireless technology. Asthmapolis, which uses… Read more . . .
-
Smartinhaler developer Nexus6 has raised NZ$1.6 million (US$1.34 million) from existing investors plus NZ$3 (US$2.5 million) from BioScience Managers, with additional funding expected to bring the total to NZ$5 million by the close of the… Read more . . .
-
According to North Carolina-based Cornerstone Therapeutics, Chiesi Farmaceutici has offered to purchase shares of Cornerstone’s common stock for between $6.40 and $6.70 per share, to take the company private. Chiesi already owns approximately 60% of… Read more . . .
-
CRO Quintiles says that it has filed a registration statement with the US. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of an undisclosed number of shares of common stock. The company… Read more . . .
-
Discovery Laboratories says that Deerfield Management Company will provide the company up to $30 million in the form of a secured loan facility. Discovery Labs will use the money for development and commercialization of its… Read more . . .
-
MeadWestvaco has announced a $7.5 million expansion of its pharmaceutical manufacturing Centre of Excellence in Hemer, Germany, an expansion the company attributes largely to growth in the preservative-free nasal product market. According to the company,… Read more . . .
-
The US Patent and Trade Office (USPTO) has granted Mystic Pharmaceuticals US Patent No. 8,377,009, according to the company. The patent, titled “Intranasal Cartridge Devices,” covers technology for a delivery system based on Mystic’s unit… Read more . . .
-
According to Pharmaxis, the company has obtained up to $40 million from NovaQuest Pharma Opportunities Fund III for development, manufacturing, and commercialization of Bronchitol mannitol inhalation powder in the US and EU. At the same… Read more . . .
-
Allergan will acquire Levadex inhaled dihydroergotamine developer MAP Pharmaceuticals for $25 per share. The two companies entered into an agreement to co-promote Levadex in January 2011, and MAP submitted an NDA for the product later… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.